Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35427190

High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2022 Jul 20
First author
Koch R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 Jul 20;40(21):2288-2290. doi: 10.1200/JCO.22.00449.
    note
    Source null
    related pmid
    35427148
    relationship
    Comment in

Authors and identifiers

  1. name
    Koch R
    type
    Author
  2. name
    Gelderblom H
    type
    Author
  3. name
    Haveman L
    type
    Author
  4. name
    Brichard B
    type
    Author
  5. name
    Jürgens H
    type
    Author
  6. name
    Cyprova S
    type
    Author
  7. name
    van den Berg H
    type
    Author
  8. name
    Hassenpflug W
    type
    Author
  9. name
    Raciborska A
    type
    Author
  10. name
    Ek T
    type
    Author
  11. name
    Baumhoer D
    type
    Author
  12. name
    Egerer G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Koch R
    type
    Author
  2. name
    Gelderblom H
    type
    Author
  3. name
    Haveman L
    type
    Author
  4. name
    Brichard B
    type
    Author
  5. name
    Jürgens H
    type
    Author
  6. name
    Cyprova S
    type
    Author
  7. name
    van den Berg H
    type
    Author
  8. name
    Hassenpflug W
    type
    Author
  9. name
    Raciborska A
    type
    Author
  10. name
    Ek T
    type
    Author
  11. name
    Baumhoer D
    type
    Author
  12. name
    Egerer G
    type
    Author
bibliography ids
  1. nci-bib-68d72ca07e2bee083f57a76b
book metadata
content sha256
eb6f1c3eb607b1e23c3618b62660c3793c5f81e4f8e4fe3c27ff0b47882e433d
document type
citation
dois
  1. 10.1200/JCO.21.01942
electronic publication date
display
2022 Apr 15
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:35427190
immutable id
pubmed:35427190@eb6f1c3eb607b1e23c3618b62660c3793c5f81e4f8e4fe3c27ff0b47882e433d
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
21
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2307-2320
volume
40
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 Jul 20;40(21):2288-2290. doi: 10.1200/JCO.22.00449.
    note
    Source null
    related pmid
    35427148
    relationship
    Comment in
outcomes validated
false
pmid
35427190
provenance
batch id
9d150d55960e0c12aada
provider
NCBI PubMed ESummary
record sha256
038ef5c252a6768ea108ee2b05ed2cc13f92e2c7d4631a239829e9a1473d84f7
response sha256
2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
retrieved at
2026-09-09T23:48:09.820498+00:00
publication date
display
2022 Jul 20
precision
day
year
2022
publication types
  1. Journal Article
  2. Multicenter Study
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35427190/
title
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.

Preserved source evidence · Not medical advice